Zacks Investment Research upgraded shares of DLH (NASDAQ:DLHC) from a hold rating to a buy rating in a report published on Wednesday. They currently have $7.00 price target on the business services provider’s stock.
According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “
Other analysts also recently issued reports about the stock. Canaccord Genuity restated a buy rating and set a $7.00 price target on shares of DLH in a research report on Friday, October 13th. TheStreet upgraded shares of DLH from a c rating to a b- rating in a report on Wednesday, November 1st. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $7.17.
DLH (NASDAQ:DLHC) last released its quarterly earnings results on Wednesday, December 6th. The business services provider reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). DLH had a return on equity of 9.61% and a net margin of 2.84%. sell-side analysts forecast that DLH will post 0.35 EPS for the current year.
In related news, major shareholder Wynnefield Partners Small Cap sold 150,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $6.15, for a total value of $922,500.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 25.90% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in DLHC. Dimensional Fund Advisors LP bought a new stake in shares of DLH in the 3rd quarter worth approximately $121,000. Essex Investment Management Co. LLC raised its holdings in shares of DLH by 149.2% in the 3rd quarter. Essex Investment Management Co. LLC now owns 71,887 shares of the business services provider’s stock worth $466,000 after purchasing an additional 43,043 shares in the last quarter. Finally, Commonwealth Equity Services Inc purchased a new position in shares of DLH in the third quarter worth approximately $2,342,000. Institutional investors and hedge funds own 54.33% of the company’s stock.
DLH Company Profile
DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans? health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.